#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness bilateral Paget's disease of the vulva Extraskeletal ossification Sarcoidosis Anal fistula B-cell small lymphocytic lymphoma recurrent Mitochondrial myopathy Acute lymphocytic leukaemia MELAS syndrome Bronchiolitis Toxic epidermal necrolysis Acute myeloid leukaemia recurrent Hairy cell leukaemia recurrent Small cell lung cancer extensive stage Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Haemophilia – Life with Disease Leiomyosarcoma recurrent Primary biliary cholangitis – Diagnostics Langerhans cell sarcoma – Treatment Lysosomal storage disorder – Treatment Breast angiosarcoma Pleural mesothelioma malignant – Trials in Disease Antisynthetase syndrome – Basic Information Sjogren’s syndrome – Treatment Von Willebrand’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunoglobulin M [14C] DC-806 Timolol Ima402 Pancreas Powder RP2 Dfv890 Posenacaftor Bdc-1001 Baclofen Tazemetostat Nicotinamide Taldefgrobep Alfa Alectinib Hydrochloride Bay 3283142 Bp1.7881A Radiprodil Tozinameran Dextran 70 Interferon Alfa More therapies…

    Learn about Your Condition

    Prostate cancer recurrent Hypocalcaemia Adenovirus infection Pulmonary resection Cerebellar ataxia Senile dementia HIV infection Premature rupture of membranes Brain neoplasm malignant Barrett's oesophagus Hypochromic anaemia Osteosarcoma metastatic Organ donor Congenital myopathy Choroid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Controlled ovarian stimulation

  • Study on Ovarian Stimulation Using Follitropin Delta and Dydrogesterone for Women Donating Eggs

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dydrogesterone
    • Follitropin Delta
    Belgium
  • Study Comparing Progesterone and Ganirelix for Preventing LH Surge in Women Undergoing Ovarian Stimulation for Egg Donation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Ganirelix
    Spain
  • Study on Ovarian Response in Women with Infertility Using Follitropin Delta and Menotrophin During Assisted Reproductive Technology

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Ganirelix
    • Menotrophin
    • Choriogonadotropin Alfa
    Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!